May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Neutralizing Antibody to VEGF164 Reduces IVNV and Capillary Density in a Rat Model of Oxygen-Induced Retinopathy
Author Affiliations & Notes
  • L. J. Peterson
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • P. Geisen
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • Y. Saito
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • X. Lu
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • D. Martiniuk
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • G. Cui
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • M. E. Hartnett
    Ophthalmology Research Labs, University of North Carolina, Chapel Hill, North Carolina
  • Footnotes
    Commercial Relationships L.J. Peterson, None; P. Geisen, None; Y. Saito, None; X. Lu, None; D. Martiniuk, None; G. Cui, None; M.E. Hartnett, None.
  • Footnotes
    Support RPB, NIH Grant EY015130, ADA 1-05-RA-51
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. J. Peterson, P. Geisen, Y. Saito, X. Lu, D. Martiniuk, G. Cui, M. E. Hartnett; Neutralizing Antibody to VEGF164 Reduces IVNV and Capillary Density in a Rat Model of Oxygen-Induced Retinopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3411.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To investigate the effects of a neutralizing anti-VEGF antibody and a receptor tyrosine kinase inhibitor of VEGF-receptor 2 (VEGFR2), on intravitreous neovascularization (IVNV), percent avascular area (%AVA), capillary density, and intraretinal cell death in a rat model of oxygen-induced retinopathy (OIR).

Methods:: We used the 50/10 OIR model that exposes Sprague-Dawley newborn rat pups to repeated cycles of 24 h of 50% oxygen alternating with 24 h of 10% oxygen until postnatal 14 days (p14), followed by exposure to room air until p18. At age p12, the right eyes of pups received 1 µL intravitreous injections of 25ng/ul or 50 ng/ul anti-VEGF neutralizing antibody, 500 ng/ml (3µM) SU5416 (VEGF-R2 inhibitor), or respective controls of nonimmune IgG or DMSO. In vivo doses were determined by assessing the effects of 1-10µM SU5416 on inhibiting receptor phosphorylation in HUVECs. All fellow eyes were noninjected. On p18 or p25, pups were sacrificed, and retinas were flat-mounted and lectin-stained for flat-mount assays (clock hours of IVNV, %AVA, capillary density, apoptosis) or processed to measure VEGF protein by ELISA.

Results:: VEGF protein was increased in OIR compared to room air pups at p12, p14 and p18 with the greatest spike at p14 (ANOVA, p=0.001). Injection of 25 µg anti-VEGF neutralizing antibody reduced mean clock hours of IVNV, 4 and 5 fold below IgG-injected and noninjected eyes respectively (ANOVA, p=0.001), and capillary density (ANOVA, p=0.008) at p18. However, there was no significant effect on IVNV, % AVA, or capillary density with several different doses of SU5416, which specifically and significantly inhibited R2 phosphorylation in HUVECs (ANOVA p<0.01).

Conclusions:: Neutralizing antibody to VEGF reduced clock hours of IVNV significantly and at a level that if translated to the clinical situation in retinopathy of prematurity (ROP) would be clinically meaningful to reduce blindness. However, the concomitant reduction in capillary density may be an undesirable effect.

Keywords: growth factors/growth factor receptors • injection • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×